Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Cetrorelix

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    14 result(s) found for: Cetrorelix. Displaying page 1 of 1.
    EudraCT Number: 2009-012847-40 Sponsor Protocol Number: Pergoveris_Cetrorelix_1 Start Date*: 2009-11-11
    Sponsor Name:NHS Lothian [...]
    1. NHS Lothian
    2. The University of Edinburgh
    Full Title: A Randomised Study Comparing Two Different Regimens of Ovarian Stimulation Using Pergoveris and Cetrorelix for Controlled Ovarian Superovulation in Assisted Conception Treatment.
    Medical condition: Subfertility
    Disease: Version SOC Term Classification Code Term Level
    12. 10042391 Subfertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-002598-30 Sponsor Protocol Number: AEZS-102-036 Start Date*: 2008-02-08
    Sponsor Name:Aeterna Zentaris GmbH
    Full Title: Cetrorelix pamoate in patients with symptomatic BPH: a double-blind placebo-controlled efficacy study
    Medical condition: Benign Prostatic Hyperplasia (PBH)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10004446 Benign prostatic hyperplasia LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: NL (Prematurely Ended) GB (Prematurely Ended) DE (Prematurely Ended) CZ (Prematurely Ended) FR (Completed) BG (Prematurely Ended) IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-004865-17 Sponsor Protocol Number: AEZS-102-041 Start Date*: 2008-08-15
    Sponsor Name:Aeterna Zentaris GmbH
    Full Title: Cetrorelix pamoate (AEZS-102) in patients with symptomatic BPH: an open-labeled safety and efficacy assessment study
    Medical condition: Benign Prostatic Hyperplasia (BPH)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10004446 Benign prostatic hyperplasia LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: BG (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-002680-13 Sponsor Protocol Number: GNRH-PES Start Date*: 2010-11-18
    Sponsor Name:Fundacion para la Investigación "Hospital Universitario Doctor Peset"
    Full Title: “Antagonistas de GnRH en el manejo del cuerpo lúteo hemorrágico. Estudio clínico y ecográfico de la luteolisis mediada por el cetrorelix”
    Medical condition: Luteolisis o regresión del cuerpo lúteo.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10011117 Corpus luteum cyst or haematoma LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-003414-34 Sponsor Protocol Number: D-20762-Z033 Start Date*: 2007-11-12
    Sponsor Name:Aeterna Zentaris GmbH
    Full Title: Cetrorelix pamoate intermittent IM dosage regimens in patients with symptomatic BPH: a 1year placebo-controlled efficacy study and long-term safety assessment
    Medical condition: Benign Prostatic Hyperplasia (PBH)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10004446 Benign prostatic hyperplasia LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DE (Prematurely Ended) BG (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-002229-30 Sponsor Protocol Number: 26170 Start Date*: 2005-09-19
    Sponsor Name:Serono España, S.A.
    Full Title: Lutropin alfa in mid follicular phase in women at risk of poor response suppresed with cetrorelix: an exploratory trial.Lutropina alfa en mitad de la fase folicular en mujeres con riesgo de pobre r...
    Medical condition: Controlled ovarian stimulation in assisted fertilisation. PT: assisted Fertilisation
    Disease: Version SOC Term Classification Code Term Level
    7.0 10003539 PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2007-000212-89 Sponsor Protocol Number: antagovo Start Date*: 2008-03-04
    Sponsor Name:Instituto Universitario IVI Valencia
    Full Title: Uso de antagonistas de la GnRH en la preparación endometrial de las receptoras de ovocitos.
    Medical condition: Comparar los resultados obtenidos con el empleo de antagonistas de la GnRH en la sincronización receptora de ovocitos–donante frente a los resultados obtenidos con el tradicional empleo de supresió...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-018009-26 Sponsor Protocol Number: FOLLPRIM Start Date*: 2010-04-14
    Sponsor Name:FUNDACION PARA LA INVESTIGACIÓN LA FE
    Full Title: PREPARACIÓN DE FOLICULOS ANTRALES, PREVIA FECUNDACION IN VITRO TIPO ICSI, EN PACIENTES CON BAJA RESPUESTA OVÁRICA. ENSAYO CLÍNICO PROSPECTIVO, ALEATORIZADO, CONTROLADO.
    Medical condition: Esterilidad femenina subsidiaria a tratamiento de fecundación in vitro.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-004460-31 Sponsor Protocol Number: PRINT Start Date*: 2007-02-21
    Sponsor Name:Guy's & St Thomas' NHS Foundation Trust
    Full Title: A randomised controlled trial comparing the gonadotrophin releasing hormone (GnRH) agonist long regimen versus the GnRH agonist short regimen versus the GnRH antagonist regimen in poor responders u...
    Medical condition: Poor ovarian response in women undergoing In vitro Fertilisation (IVF) treatment.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10056204 In vitro fertilisation PT
    Population Age: Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2021-005005-28 Sponsor Protocol Number: ADENOFERT Start Date*: 2022-11-08
    Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA
    Full Title: Assisted reproductive technology (ART) and pregnancy outcomes in women with adenomyosis (internal endometriosis) according to stimulation protocol in relation to immunological and endometrial featu...
    Medical condition: Women with transvaginal ultrasound (TV-US)-based diagnosis of adenomyosis and women without adenomyosis but with similar baseline reproductive risks
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10014778 Endometriosis PT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2018-001915-63 Sponsor Protocol Number: 13710 Start Date*: 2018-11-15
    Sponsor Name:University of Oxford / Clinical Trials and Research Governance
    Full Title: A randomised controlled pilot trial of the use of GnRH-antagonist pituitary suppression during medicated frozen-thawed embryo transfer (FET) cycles
    Medical condition: Infertility
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004872 10016398 Female infertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2012-004824-39 Sponsor Protocol Number: 1 Start Date*: 2015-09-18
    Sponsor Name:UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST
    Full Title: The use of GnRH antagonist versus co-flare protocol for women with low ovarian reserve undergoing first cycle of in vitro fertilization
    Medical condition: response to ovarian stimulation in women with reduced ovarian reserve undergoing first cycle of in vitro fertilisaion.
    Disease: Version SOC Term Classification Code Term Level
    17.0 10042613 - Surgical and medical procedures 10056204 In vitro fertilisation PT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2012-003412-31 Sponsor Protocol Number: BROVALE-2012(BC-POF2012) Start Date*: 2012-10-01
    Sponsor Name:CUB - Hôpital Erasme
    Full Title: Efficiency and Safety of Ovarian Stimulation with Letrozole for fertility preservation in breast cancer patients.
    Medical condition: The aim of this trial is to offer a safe and efficient alternative protocol to preserve fertility by storing oocytes in breast cancer patients before chemotherapy. Letrozole, an inhibitor of aromat...
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004864 10006190 Breast cancer invasive NOS LLT
    18.1 100000004872 10016465 Fertility female decreased LLT
    18.1 100000004872 10016463 Fertility decreased female LLT
    Population Age: Adults Gender: Female
    Trial protocol: BE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-002482-19 Sponsor Protocol Number: 13EU/FSH01 Start Date*: 2013-12-12
    Sponsor Name:IBSA Institut Biochimique S.A.
    Full Title: Randomised clinical trial comparing highly purified FSH formulation (Fostimon®) and recombinant FSH (Gonal-F®) in GnRH-antagonist controlled ovarian hyperstimulation cycles.
    Medical condition: female infertility
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004872 10016398 Female infertility LLT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed) GB (Completed) ES (Completed) BE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 19 22:26:29 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA